To include your compound in the COVID-19 Resource Center, submit it here.

SB-240563: Phase II

Researchers published in The Lancet results of a trial of 24

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE